Stapley Marc
SEC CIK 1539796 · EDGAR
BoughtSold
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 56
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 19:53 | 2026-09-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $44.88 | -8,782 | 432.1K | -2% | -$394.1K | |
| DT | 2026-06-04 21:38 | 2026-06-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $47.80 | -9,012 | 440.5K | -2% | -$430.8K |
| DT | 2026-06-04 21:38 | 2026-06-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | M - OptEx | $36.60 | +138.1K | 578.5K | +31% | +$5.05M |
| DT | 2026-06-04 21:38 | 2026-06-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale+OE | $50.12 | -138.1K | 440.5K | -24% | -$6.92M |
| D | 2026-06-01 18:10 | 2026-05-28 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,878 | 39.3K | +5% | $0 |
| 2026-03-10 | 2026-03-06 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +92.1K | 449.7K | +26% | $0 | |
| M | 2026-03-06 | 2026-03-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale | $35.98 | -45.5K | 383.8K | -11% | -$1.64M |
| 2026-03-04 | 2026-03-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $36.01 | -19.5K | 403.1K | -5% | -$700.6K | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +139.1K | 458.4K | +44% | $0 | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $38.75 | -35.8K | 422.5K | -8% | -$1.39M | |
| DM | 2026-01-26 | 2026-01-22 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | S - Sale+OE | $127.71 | -15.0K | 48.6K | -24% | -$1.92M |
| D | 2026-01-26 | 2026-01-22 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | M - OptEx | $24.69 | +15.0K | 52.4K | +40% | +$370.4K |
| 2026-01-07 | 2026-01-02 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +727 | 37.4K | +2% | $0 | |
| 2025-12-04 | 2025-12-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $46.16 | -7,914 | 326.3K | -2% | -$365.3K | |
| M | 2025-12-04 | 2025-12-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale | $47.09 | -7,668 | 318.6K | -2% | -$361.1K |
| 2025-09-08 | 2025-09-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale | $30.41 | -7,667 | 334.2K | -2% | -$233.2K | |
| 2025-09-04 | 2025-09-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $30.11 | -7,914 | 341.9K | -2% | -$238.3K | |
| 2025-06-04 | 2025-06-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $26.74 | -9,399 | 349.2K | -3% | -$251.3K | |
| DM | 2025-06-02 | 2025-01-02+ | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +2,646 | 36.7K | +8% | $0 |
| 2025-03-10 | 2025-03-06 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +90.6K | 358.6K | +34% | $0 | |
| M | 2025-03-06 | 2025-03-04 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale | $33.34 | -52.7K | 292.5K | -15% | -$1.76M |
| M | 2025-03-03 | 2025-02-27+ | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $34.18 | -54.6K | 341.1K | -14% | -$1.87M |
| 2025-03-03 | 2025-02-27 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +67.3K | 375.3K | +22% | $0 | |
| M | 2024-12-17 | 2024-12-13 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | S - Sale | $43.43 | -5,590 | 307.3K | -2% | -$242.7K |
| 2024-12-04 | 2024-12-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $44.12 | -5,748 | 312.9K | -2% | -$253.6K | |
| 2024-09-04 | 2024-09-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $31.55 | -5,748 | 318.7K | -2% | -$181.3K | |
| D | 2024-08-19 | 2024-08-15 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | M - OptEx | $32.00 | +6,250 | 40.3K | +18% | +$200.0K |
| DM | 2024-08-19 | 2024-08-15 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | S - Sale+OE | $125.93 | -6,250 | 38.6K | -14% | -$787.1K |
| 2024-06-04 | 2024-06-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $20.75 | -5,746 | 324.0K | -2% | -$119.2K | |
| D | 2024-06-03 | 2024-05-30 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,716 | 34.1K | +5% | $0 |
| D | 2024-05-16 | 2024-05-15 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | M - OptEx | $32.00 | +6,250 | 38.6K | +19% | +$200.0K |
| DM | 2024-05-16 | 2024-05-15 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | S - Sale+OE | $112.80 | -6,250 | 36.6K | -15% | -$705.0K |
| 2024-03-19 | 2024-03-15 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +11.8K | 335.7K | +4% | $0 | |
| 2024-03-19 | 2024-03-15 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $21.10 | -5,971 | 329.7K | -2% | -$126.0K | |
| 2024-03-08 | 2024-03-06 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +114.7K | 323.9K | +55% | $0 | |
| 2024-03-05 | 2024-03-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $24.00 | -13.3K | 209.2K | -6% | -$318.9K | |
| D | 2024-03-04 | 2024-02-29 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | M - OptEx | $32.00 | +6,250 | 38.6K | +19% | +$200.0K |
| DM | 2024-03-04 | 2024-02-29 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | S - Sale+OE | $90.09 | -6,250 | 36.2K | -15% | -$563.1K |
| A | 2024-03-04 | 2024-01-02 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,044 | 32.4K | +3% | $0 |
| 2024-01-04 | 2024-01-02 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,082 | 32.4K | +3% | $0 | |
| DM | 2023-12-18 | 2023-12-14 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | S - Sale+OE | $75.93 | -16.2K | 31.3K | -34% | -$1.23M |
| DM | 2023-12-18 | 2023-12-14 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | M - OptEx | $16.79 | +16.2K | 41.3K | +65% | +$272.8K |
| 2023-12-05 | 2023-12-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $26.54 | -3,203 | 221.9K | -1% | -$85.0K | |
| 2023-09-06 | 2023-09-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $26.70 | -3,204 | 225.1K | -1% | -$85.5K | |
| 2023-06-06 | 2023-06-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $26.72 | -3,203 | 227.7K | -1% | -$85.6K | |
| 2023-06-05 | 2023-06-01 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +3,230 | 31.3K | +12% | $0 | |
| D | 2023-03-09 | 2023-03-06 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +78.0K | 230.9K | +51% | $0 |
| 2023-03-03 | 2023-03-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $24.10 | -6,029 | 152.9K | -4% | -$145.3K | |
| 2023-01-04 | 2023-01-03 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,900 | 28.1K | +7% | $0 | |
| 2022-12-06 | 2022-12-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $29.14 | -1,012 | 158.3K | -0.6% | -$29.5K | |
| 2022-09-07 | 2022-09-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $19.18 | -1,012 | 159.3K | -0.6% | -$19.4K | |
| 2022-06-13 | 2022-06-10 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | P - Purchase | $16.33 | +60.0K | 159.8K | +60% | +$979.8K | |
| 2022-06-06 | 2022-06-02 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +4,364 | 26.2K | +20% | $0 | |
| 2022-06-06 | 2022-06-02 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | F - Tax | $18.23 | -4,047 | 99.8K | -4% | -$73.8K | |
| D | 2022-03-07 | 2022-03-03 | VCYT | VERACYTE, INC. | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +56.5K | 103.8K | +120% | $0 |
| 2022-01-05 | 2022-01-03 | GKOS | GLAUKOS Corp | Stapley Marc | Dir | A - Grant | $0.00 | +1,758 | 21.8K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations